Porphobilinogen deaminase [PBGD; porphobilinogen ammonia-lyase (polymerizing), EC 4.3
. When these mechanisms involve coding regions, several proteins can be synthesized and the genes encoding the isozymes are a fruitful material to study the molecular basis of such processes. If two isozymes are encoded by mRNAs transcribed from two promoters, these can be both tissue specific (8) , both housekeeping (11), or one can be housekeeping and the other can be tissue specific. The third class has not been documented so far, and we present here data that describe the structure of a single gene having this dual purpose.
Porphobilinogen deaminase [PBGD; porphobilinogen ammonia-lyase (polymerizing), EC 4.3.1.8] is the third enzyme of the heme biosynthetic pathway. Two isoforms of this enzyme, one found in all cells and the other found only in erythroid cells, can be distinguished (12) and it has been recently demonstrated that these two isoforms are translated from two mRNAs that differ solely in their5' termini (13) . We have shown that a single structural gene encodes these isoenzymes (14) and the present report documents the regulated generation ofthese two isoforms from that single gene. The gene encoding PBGD is 10 kilobases (kb) long and is split into 15 exons. It is transcribed into two distinct mRNAs through alternative splicing of two primary transcripts arising from two promoters separated by 3 kb of DNA. The upstream promoter, which is active in all cells, has features of housekeeping promoters (15) . The downstream promoter is active only in erythroid cells and a comparison with the human P3-globin gene promoter suggests a modular organization [5' CAAC box. . .6 base pairs (bp)... .CAAT box... .TATA box cap.... 3'] , which might be common to a set of erythroid specific promoters.
MATERIALS AND METHODS
Isolation of Recombinant Cosmids. A human cosmid library (provided by C. Y. Lau, Howard Hughes Medical Institute, San Francisco) was screened and hybridizing cosmids were isolated (16) . Their physical mapping was performed by a combination of single and double digestion of cosmid DNA (17) .
Nucleotide Sequencing. The cloned human PBGD gene was cut with various enzymes and subcloned into M13mp8 or M13mp9 (18) . The chain-terminator sequence procedure (19) was then performed. Sequence data were stored and processed with the DB system programs of Staden (20) .
Primer Extension and S1 Protection Experiments. For primer extension, the DNA fragment or the oligomer indicated for each reaction was labeled at one 5' For S1 nuclease mapping, the hybridization was also done overnight. The hybridization mixture was then diluted 1:10 with S1 nuclease buffer and 400 units of S1 nuclease (Boehringer Mannheim) was added for 10 min at 37°C. The mixture was then phenol extracted, ethanol precipitated, and loaded on a sequencing gel. RESULTS Isolation of PBGD Genomic Clones. Four genome equivalents of cloned human DNA were screened for hybridization to a Kpn I/Sma I fragment common to PBGD cDNAs isolated from erythroid and nonerythroid tissues (13, 14 tTo whom reprint requests should be addressed.
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Mapping, Sequencing, and Exon-Intron Organization of the PBGD Gene. Exon sequences were first localized by hybridization of various 32P-labeled fragments isolated from PBGD cDNAs to restriction enzyme digests ofcloned genomic DNA from COS PBGD7. The sequences recognized by these fragments span at least 10 kb. The precise locations of all the exon-intron boundaries, as well as the whole sequence of the gene except introns 3 and 9, were determined. Fig. 1 summarizes the results of this sequence. The gene contains 15 exons and 14 introns and all the sequences found around the intron-exon junctions are in agreement with the consensus sequences described (21) . The 5'-terminal segment of the ubiquitous PBGD mRNA is transcribed from exon 1, which lies 3.1 kb upstream from the common region of the two mRNAs. In this case, the primary transcript is spliced so that exon 1 is linked to exon 3 ( Fig. 1) . In contrast, the 5'-terminal segment of the erythroid PBGD mRNA is transcribed from exon 2, which lies 2.9 kb 3' to exon 1 and 175 bp upstream from exon 3. The primary transcript is then spliced so that exon 2 is linked to exon 3 ( Fig. 1) . Both erythroid and ubiquitous mRNAs contain sequences transcribed from exon 3 to exon 15.
5' End of the PBGD Gene. The most striking aspect of this gene is its organization in ubiquitous and tissue-specific pieces. As the entire 5' untranslated regions of the ubiquitous and erythroid-specific mRNAs were not available (13, 14) , we had to map the start points of transcription to decide whether these two mRNAs were produced by transcription from different promoters or derived from a unique primary transcript through differential splicing. In the latter case, they would share a common 5' leader sequence.
To locate precisely the 5' end of the ubiquitous mRNA, 27-mer complementary to a specific part of the nonerythroid mRNA was labeled at its 5' end and used either for primer extension, or for S1 nuclease mapping after the synthesis of a single-stranded probe extending from the primer to a Pvu II site located 256 bases upstream. Fig. 2A shows the result of both experiments. Indeed, multiple initiation sites, clustered between 124 and 155 bases upstream from the initiation codon, are revealed using RNA isolated from erythroid or nonerythroid tissues or cell lines. The identical pattern of initiation obtained with S1 nuclease mapping and primer AUG extension shows that no exon common to both mRNAs lies 5' from the determined initiation region and suggests the existence of a specific promoter for the expression of the ubiquitous PBGD gene. The sequences of this promoter region, as well as exon 1 and the beginning of the first intron, are shown in Fig. 2B .
To define the length of the 5' noncoding part of the erythroid mRNA and to localize its cap site, a probe was generated extending from a 5'-end-labeled BamHI site present in exon 2 to either an Ava II site located 38 nucleotides upstream (for the primer extension) or an Alu I site located 130 nucleotides upstream (for S1 nuclease mapping). After hybridization with erythrocytic mRNA, the hybrids were either extended with reverse transcriptase or digested with S1 nuclease. This combination of S1 nuclease mapping and primer extension demonstrates (Fig. 3A) that the erythrocytic mRNA arises from a unique start point located 31 bp upstream from the 5' end of the longest cDNA we have cloned (14) . This start point as well as the sequence of the 5' flanking region of exon 2, exon 2, and the beginning of intron 2 are shown in Fig. 3B .
Tissue Specificity of the Expression of the Downstream Promoter. To assess precisely which type of PBGD mRNA is present in different tissues and cell lines, we performed a primer extension assay using a 5' terminally labeled oligomer specific of the mRNA initiated at the downstream promoter. As shown in Fig. 4 Fig. 2) ] functions as such, nor the CAAT box (22) . Two regions, one located around -185 and one located around -230 are of interest. The distal region consists of a direct 13-bp repeat and the proximal region consists of two SP1 binding sites (with 80o and 90o similarity to the SP1 consensus sequence) separated by one base. All the housekeeping genes bearing this modular organization (i.e., no TATA and CAAT boxes but a cluster ofSP1 binding sites) are either regulated during the cell cycle (23) or subjected to feedback regulation by products of the biosynthetic pathway in which they are involved (24) . At present, no data can correlate the activity of PBGD to the cell cycle or to the regulation of heme biosynthesis in nonerythroid tissues, where 6-aminolevulinic acid synthase seems to be the key enzyme (25 The first element, located between -26 and -31 is the ATAAAA box and is required for efficient in vivo and in vitro transcription (27) . As shown in Fig. 5 The second P-globin element, located between -70 and -78, is the GGCCAATCT sequence (CAAT box), which is also required for efficient transcription of the rabbit or mouse major 3-globin genes when transiently transfected into nonerythroid cells in culture (27, 29) . In the erythroid PBGD gene promoter, the sequence 5' GGCCAGGCT 3' is found between -82 and -90-i.e., one helix turn farther than in the ,3-globin gene promoters. This sequence is also similar to the CAAT box sequence and the two substitutions observed might be related to the efficiency of transcription of this promoter. These two elements, the TATA box and the CAAT box, are also found in a number of eukaryotic genes that are tissue specific, so it is not surprising to find similar sequences in this PBGD promoter. The third element, located 6 bases upstream from the C CAAT box is the CAAC box (5' GCCACACCCT 3'). This T element is found in most of the /3-globin gene promoters but not in other tissue-specific genes. It is required for efficient in vivo expression of /3-globin genes (26) and is often duplicated. A sequence, 5' GCCCCACCCT 3', completely similar to this CAAC box is located 6 bases upstream from the CAAT box in the erythroid promoter of the PBGD gene and is partially duplicated (Fig. 3) . Thus, the modular structure of the /8-globin and the erythroid PBGD promoters are very similar, the /B-globin-specific module (CAAC box) being much better conserved than the TATA and CAAT boxes. Together with a previous study that showed the expression of f3-globin mRNA and PBGD are among the earliest events characterizing erythroid cell differentiation (30) , this suggests the use of a common modular structure for the constitutive expression of numerous genes activated during erythroid differentiation; point mutations within these modules would precisely tune the level of expression of these genes.
